Co-Targeting of BTK and TrxR as a Therapeutic Approach to the Treatment of Lymphoma

Diffuse large B-cell lymphoma (DLBCL) is a haematological malignancy representing the most diagnosed non-Hodgkin’s lymphoma (NHL) subtype. Despite the approved chemotherapies available in clinics, some patients still suffer from side effects and relapsed disease. Recently, studies have reported the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Sicong, Clapper, Erin, Tonissen, Kathryn F., Di Trapani, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952695/
https://www.ncbi.nlm.nih.gov/pubmed/36830087
http://dx.doi.org/10.3390/antiox12020529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952695/
https://www.ncbi.nlm.nih.gov/pubmed/36830087
http://dx.doi.org/10.3390/antiox12020529

Ejemplares similares